| Bid | 0.54 |
| Market Cap | 2.86M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.79 |
| PE Ratio (ttm) | -0.29 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.56 |
| Volume | 708,450 |
| Avg. Volume (20D) | 783,647 |
| Open | 0.50 |
| Previous Close | 0.49 |
| Day's Range | 0.49 - 0.53 |
| 52-Week Range | 0.31 - 1.34 |
| Beta | undefined |
About YCBD
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its prod...
Analyst Forecast
According to 1 analyst ratings, the average rating for YCBD stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Next Earnings Release
Analysts project revenue of $5.19M, reflecting a -3.44% YoY shrinking and earnings per share of -0.37, making a -44.78% decrease YoY.
2 months ago · newsfilecorp.com
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC SeltzersCharlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) a trusted leader in the wellness and cannabinoid industry, is excited to an...